BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17575142)

  • 1. c-FLIP: a key regulator of colorectal cancer cell death.
    Wilson TR; McLaughlin KM; McEwan M; Sakai H; Rogers KM; Redmond KM; Johnston PG; Longley DB
    Cancer Res; 2007 Jun; 67(12):5754-62. PubMed ID: 17575142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
    Longley DB; Wilson TR; McEwan M; Allen WL; McDermott U; Galligan L; Johnston PG
    Oncogene; 2006 Feb; 25(6):838-48. PubMed ID: 16247474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
    Day TW; Huang S; Safa AR
    Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-FLIP, a master anti-apoptotic regulator.
    Safa AR
    Exp Oncol; 2012 Oct; 34(3):176-84. PubMed ID: 23070002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.
    Zou W; Liu X; Yue P; Khuri FR; Sun SY
    Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
    Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
    J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.
    Wilson TR; Redmond KM; McLaughlin KM; Crawford N; Gately K; O'Byrne K; Le-Clorrenec C; Holohan C; Fennell DA; Johnston PG; Longley DB
    Cell Death Differ; 2009 Oct; 16(10):1352-61. PubMed ID: 19543235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.
    Mahalingam D; Natoni A; Keane M; Samali A; Szegezdi E
    Br J Cancer; 2010 Feb; 102(4):754-64. PubMed ID: 20087343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
    Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S
    Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
    Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
    J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells.
    Wilson TR; McEwan M; McLaughlin K; Le Clorennec C; Allen WL; Fennell DA; Johnston PG; Longley DB
    Oncogene; 2009 Jan; 28(1):63-72. PubMed ID: 18820704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
    Lees A; McIntyre AJ; Crawford NT; Falcone F; McCann C; Holohan C; Quinn GP; Roberts JZ; Sessler T; Gallagher PF; Gregg GMA; McAllister K; McLaughlin KM; Allen WL; Egan LJ; Ryan AE; Labonte-Wilson MJ; Dunne PD; Wappett M; Coyle VM; Johnston PG; Kerr EM; Longley DB; McDade SS
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17808-17819. PubMed ID: 32661168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCF
    Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB
    Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
    Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
    Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.
    Galligan L; Longley DB; McEwan M; Wilson TR; McLaughlin K; Johnston PG
    Mol Cancer Ther; 2005 Dec; 4(12):2026-36. PubMed ID: 16373718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
    Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
    Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting c-FLIP in cancer.
    Shirley S; Micheau O
    Cancer Lett; 2013 May; 332(2):141-50. PubMed ID: 21071136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide.
    Logan AE; Wilson TR; Fenning C; Cummins R; Kay E; Johnston PG; Longley DB
    Apoptosis; 2010 Dec; 15(12):1435-43. PubMed ID: 20683665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.